Engineered multispecific antibodies and other multimeric proteins with asymmetrical CH2-CH3 region mutations
US11149094B2 · kind B2 · utility
6Cited by
17References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 4, 2018 |
| Grant date | Oct 19, 2021 |
| Priority date | — |
| Expiry date | Jul 13, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to engineered multispecific antibodies and other multimeric proteins with asymmetrical CH2-CH3 region mutations and methods of making and using them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.